Yahoo Finance

Asklepion Pharmaceuticals LLC announces AWINSA Life Sciences as its Clinical safety and Pharmacovigilance Service provider for their clinical trials in their fight against COVID-19

PRINCETON, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- AWINSA Life Sciences, a Pharmacovigilance and Clinical Safety service provider announced that it has been selected as the preferred vendor for ...
Yahoo Finance

Asklepion Pharmaceuticals Signs Contract to Utilize NetraMark Technology in Phase III Pediatric Cardiac Study

TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company ...
FierceBiotech

Retrophin Announces Acquisition of Exclusive Right to Purchase Cholic Acid from Asklepion Pharmaceuticals

Retrophin, Inc. (RTRX) and Asklepion Pharmaceuticals, LLC, a privately held rare disease pharmaceutical development company, today announced the signing of a definitive agreement under which Retrophin ...
FiercePharma

FDA green-lights Asklepion's Cholbam; Pfizer's Australian court fight over Lipitor discounting isn't over yet;

> The FDA approved Cholbam, a new drug from Baltimore-based Asklepion Pharmaceuticals, to treat bile acid and peroxisomal disorders in kids and adults. Release > Australia's expert body that ...
Mena FN

Asklepion Pharmaceuticals Signs Contract To Utilize Netramark Technology In Phase III Pediatric Cardiac Study

(MENAFN- GlobeNewsWire - Nasdaq) TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the“Company” or“NetraMark”) (CSE: AIAI) (OTCQB: AINMF ...
Finanznachrichten

NetraMark Holdings Inc.: Asklepion Pharmaceuticals Signs Contract to Utilize NetraMark Technology in Phase III Pediatric Cardiac Study

TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company ...